
Amgen announced it will present at the Bank of America Merrill Lynch Global Healthcare Conference on May 13, 2026, with key executives Peter Griffith and Jay Bradner speaking. The presentation will be webcast live and available for replay on Amgen's website, providing updates on the company's innovations and pipeline in biotechnology. This event offers investors and the public insight into Amgen's progress in developing treatments for cancer, inflammatory diseases, and other conditions. The webcast will remain accessible for at least 90 days after the event.